127 related articles for article (PubMed ID: 35846513)
21. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
Viruses; 2022 May; 14(5):. PubMed ID: 35632769
[TBL] [Abstract][Full Text] [Related]
22. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools.
Nag A; Paul S; Banerjee R; Kundu R
Comput Biol Med; 2021 Oct; 137():104818. PubMed ID: 34481181
[TBL] [Abstract][Full Text] [Related]
23. Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface.
Ogedjo M; Onoka I; Sahini M; Shadrack DM
Biochem Biophys Rep; 2021 Sep; 27():101024. PubMed ID: 34056140
[TBL] [Abstract][Full Text] [Related]
24. An
Stalin A; Lin D; Senthamarai Kannan B; Feng Y; Wang Y; Zhao W; Ignacimuthu S; Wei DQ; Chen Y
J Biomol Struct Dyn; 2022 Oct; 40(16):7408-7423. PubMed ID: 33685364
[TBL] [Abstract][Full Text] [Related]
25. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
Ali N; Khan R; AlAsmari AF; Kumar V
Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
[TBL] [Abstract][Full Text] [Related]
26. Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro.
Omotuyi O; Olatunji OM; Nash O; Oyinloye B; Soremekun O; Ijagbuji A; Fatumo S
Microb Pathog; 2023 Mar; 176():105994. PubMed ID: 36682669
[TBL] [Abstract][Full Text] [Related]
27. ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor.
Souza PFN; Amaral JL; Bezerra LP; Lopes FES; Freire VN; Oliveira JTA; Freitas CDT
J Biomol Struct Dyn; 2022 Aug; 40(12):5493-5506. PubMed ID: 33427102
[TBL] [Abstract][Full Text] [Related]
28. Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations.
Patel CN; Goswami D; Jaiswal DG; Parmar RM; Solanki HA; Pandya HA
J Mol Graph Model; 2021 Jun; 105():107874. PubMed ID: 33647752
[TBL] [Abstract][Full Text] [Related]
29. Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis.
Siddiqui S; Upadhyay S; Ahmad R; Barkat MA; Jamal A; Alothaim AS; Hassan MZ; Rahman MA; Arshad M; Ahamad T; Khan MF; Shankar H; Ali M; Kaleem S; Ahmad J
Appl Biochem Biotechnol; 2022 Dec; 194(12):5918-5944. PubMed ID: 35838886
[TBL] [Abstract][Full Text] [Related]
30. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
31. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
32. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
Dehury B; Raina V; Misra N; Suar M
J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417
[TBL] [Abstract][Full Text] [Related]
33. A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2).
Coghi P; Yang LJ; Ng JPL; Haynes RK; Memo M; Gianoncelli A; Wong VKW; Ribaudo G
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681178
[TBL] [Abstract][Full Text] [Related]
34. Bioactivity of
Rizzo R; Pistillo M; Germinara GS; Lo Verde G; Sinacori M; Maggi F; Petrelli R; Spinozzi E; Cappellacci L; Zeni V; Canale A; Benelli G
Insects; 2021 Sep; 12(10):. PubMed ID: 34680649
[TBL] [Abstract][Full Text] [Related]
35. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
36. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
37. Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay.
Xiang Y; Zhai G; Li Y; Wang M; Chen X; Wang R; Xie H; Zhang W; Ge G; Zhang Q; Xu Y; Caflisch A; Xu J; Chen H; Chen L
Int J Biol Macromol; 2023 Jan; 226():780-792. PubMed ID: 36521705
[TBL] [Abstract][Full Text] [Related]
38. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
Jafary F; Jafari S; Ganjalikhany MR
Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
[TBL] [Abstract][Full Text] [Related]
39. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
Gollapalli P; B S S; Rimac H; Patil P; Nalilu SK; Kandagalla S; Shetty P
J Biomol Struct Dyn; 2022 Apr; 40(6):2701-2714. PubMed ID: 33146070
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection.
Chaouat AE; Achdout H; Kol I; Berhani O; Roi G; Vitner EB; Melamed S; Politi B; Zahavy E; Brizic I; Lenac Rovis T; Alfi O; Wolf D; Jonjic S; Israely T; Mandelboim O
PLoS Pathog; 2021 Dec; 17(12):e1010175. PubMed ID: 34929007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
